Johnson & Johnson Goodwill, Acquired During Period
Johnson & Johnson (JNJ) reported Goodwill, Acquired During Period of $3.00 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-07-23
- Johnson & Johnson goodwill, acquired during period for the quarter ending 2026-06-28 was $3.00M, a 99.90% decline year-over-year.
- Johnson & Johnson goodwill, acquired during period for the quarter ending 2026-03-29 was $0.00.
- Johnson & Johnson goodwill, acquired during period for the quarter ending 2025-12-28 was $642.00M, a 2818.18% increase year-over-year.
- Johnson & Johnson goodwill, acquired during period for the quarter ending 2025-09-28 was -$30.00M, a 123.08% decline year-over-year.
- Johnson & Johnson goodwill, acquired during period for fiscal 2025 was $3.49B, a 57.51% decline from fiscal 2024.
- Johnson & Johnson goodwill, acquired during period for fiscal 2024 was $8.21B.
- Johnson & Johnson goodwill, acquired during period for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2023.
- Johnson & Johnson goodwill, acquired during period for fiscal 2023 was $11.06B.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month |
|---|---|---|---|---|
| 2026-06-28 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | $3.00M 10-Q · filed 2026-07-23 | $645.00M derived: sum of 3 quarters · filed 2026-07-23 | $615.00M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-29 | $0.00 10-Q · filed 2026-04-22 | $642.00M derived: sum of 2 quarters · filed 2026-04-22 | $612.00M derived: sum of 3 quarters · filed 2026-04-22 | $3.49B derived: sum of 4 quarters · filed 2026-04-22 |
| 2025-12-28 | $642.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $612.00M derived: sum of 2 quarters · filed 2026-02-11 | $3.49B derived: sum of 3 quarters · filed 2026-02-11 | $3.49B 10-K · filed 2026-02-11 |
| 2025-09-28 | -$30.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22 | $2.85B derived: sum of 2 quarters · filed 2025-10-22 | $2.85B 10-Q · filed 2025-10-22 | $2.87B derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-29 | $2.88B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-24 | $2.88B 10-Q · filed 2025-07-24 | $2.90B derived: sum of 3 quarters · filed 2026-02-11 | $3.03B derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-30 | $0.00 10-Q · filed 2025-04-23 | $22.00M derived: sum of 2 quarters · filed 2026-02-11 | $152.00M derived: sum of 3 quarters · filed 2026-02-11 | $7.92B derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-29 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $152.00M derived: sum of 2 quarters · filed 2026-02-11 | $7.92B derived: sum of 3 quarters · filed 2026-02-11 | $8.21B 10-K · filed 2026-02-11 |
| 2024-09-29 | $130.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-23 | $7.90B derived: sum of 2 quarters · filed 2024-10-23 | $8.19B 10-Q · filed 2024-10-23 | $8.19B derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-06-30 | $7.77B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25 | $8.06B 10-Q · filed 2024-07-25 | $8.06B derived: sum of 3 quarters · filed 2025-02-13 | $8.06B derived: sum of 4 quarters · filed 2025-02-13 |
| 2024-03-31 | $290.00M 10-Q · filed 2024-05-01 | $290.00M derived: sum of 2 quarters · filed 2025-02-13 | $290.00M derived: sum of 3 quarters · filed 2025-02-13 | $290.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $0.00 derived: sum of 2 quarters · filed 2025-02-13 | $0.00 derived: sum of 3 quarters · filed 2025-02-13 | $0.00 10-K · filed 2025-02-13 |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $0.00 derived: sum of 2 quarters · filed 2023-10-27 | $0.00 10-Q · filed 2023-10-27 | $10.86B derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-07-02 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $0.00 10-Q · filed 2023-07-31 | $10.86B derived: sum of 3 quarters · filed 2024-02-16 | $10.86B derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-04-02 | $0.00 10-Q · filed 2023-04-28 | $10.86B derived: sum of 2 quarters · filed 2024-02-16 | $10.86B derived: sum of 3 quarters · filed 2024-02-16 | $10.98B derived: sum of 4 quarters · filed 2024-02-16 |
| 2023-01-01 | $10.86B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $10.86B derived: sum of 2 quarters · filed 2024-02-16 | $10.98B derived: sum of 3 quarters · filed 2024-02-16 | $11.06B 10-K · filed 2024-02-16 |
| 2022-10-02 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $122.00M derived: sum of 2 quarters · filed 2022-10-27 | $195.00M 10-Q · filed 2022-10-27 | $195.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2022-07-03 | $122.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $195.00M 10-Q · filed 2022-07-29 | $195.00M derived: sum of 3 quarters · filed 2023-02-16 | $195.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2022-04-03 | $73.00M 10-Q · filed 2022-04-29 | $73.00M derived: sum of 2 quarters · filed 2023-02-16 | $73.00M derived: sum of 3 quarters · filed 2023-02-16 | $73.00M derived: sum of 4 quarters · filed 2023-02-16 |
| 2022-01-02 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $0.00 derived: sum of 2 quarters · filed 2023-02-16 | $0.00 derived: sum of 3 quarters · filed 2023-02-16 | $0.00 10-K · filed 2023-02-16 |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | $0.00 10-Q · filed 2021-10-29 | $1.28B derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-07-04 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | $1.28B derived: sum of 3 quarters · filed 2022-02-17 | $1.28B derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-04-04 | $0.00 10-Q · filed 2021-04-30 | $1.28B derived: sum of 2 quarters · filed 2022-02-17 | $1.28B derived: sum of 3 quarters · filed 2022-02-17 | $1.30B derived: sum of 4 quarters · filed 2022-02-17 |
| 2021-01-03 | $1.28B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $1.28B derived: sum of 2 quarters · filed 2022-02-17 | $1.30B derived: sum of 3 quarters · filed 2022-02-17 | $1.46B 10-K · filed 2022-02-17 |
| 2020-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $27.00M derived: sum of 2 quarters · filed 2020-10-23 | $184.00M 10-Q · filed 2020-10-23 | $256.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2020-06-28 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $184.00M 10-Q · filed 2020-07-24 | $256.00M derived: sum of 3 quarters · filed 2021-02-22 | $250.00M derived: sum of 4 quarters · filed 2021-02-22 |
| 2020-03-29 | $157.00M 10-Q · filed 2020-04-29 | $229.00M derived: sum of 2 quarters · filed 2021-02-22 | $223.00M derived: sum of 3 quarters · filed 2021-02-22 | $2.24B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-12-29 | $72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $66.00M derived: sum of 2 quarters · filed 2021-02-22 | $2.08B derived: sum of 3 quarters · filed 2021-02-22 | $3.28B 10-K · filed 2021-02-22 |
| 2019-09-29 | -$6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $2.01B derived: sum of 2 quarters · filed 2019-10-28 | $3.21B 10-Q · filed 2019-10-28 | $3.18B derived: sum of 4 quarters · filed 2020-02-18 |
| 2019-06-30 | $2.02B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $3.21B 10-Q · filed 2019-07-29 | $3.19B derived: sum of 3 quarters · filed 2020-02-18 | $3.51B derived: sum of 4 quarters · filed 2020-02-18 |
| 2019-03-31 | $1.20B 10-Q · filed 2019-05-01 | $1.17B derived: sum of 2 quarters · filed 2020-02-18 | $1.50B derived: sum of 3 quarters · filed 2020-02-18 | $1.55B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-12-30 | -$25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $299.00M derived: sum of 2 quarters · filed 2020-02-18 | $350.00M derived: sum of 3 quarters · filed 2020-02-18 | $403.00M 10-K · filed 2020-02-18 |
| 2018-09-30 | $324.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $375.00M derived: sum of 2 quarters · filed 2018-10-31 | $428.00M 10-Q · filed 2018-10-31 | $892.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2018-07-01 | $51.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $104.00M 10-Q · filed 2018-08-02 | $568.00M derived: sum of 3 quarters · filed 2019-02-20 | $489.00M derived: sum of 4 quarters · filed 2019-02-20 |
| 2018-04-01 | $53.00M 10-Q · filed 2018-05-01 | $517.00M derived: sum of 2 quarters · filed 2019-02-20 | $438.00M derived: sum of 3 quarters · filed 2019-02-20 | $6.47B derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-12-31 | $464.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $385.00M derived: sum of 2 quarters · filed 2019-02-20 | $6.41B derived: sum of 3 quarters · filed 2019-02-20 | $8.46B 10-K · filed 2019-02-20 |
| 2017-10-01 | -$79.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $5.95B derived: sum of 2 quarters · filed 2017-11-02 | $8.00B 10-Q · filed 2017-11-02 | $8.06B derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-07-02 | $6.03B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $8.08B 10-Q · filed 2017-08-03 | $8.14B derived: sum of 3 quarters · filed 2018-02-21 | $9.24B derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-04-02 | $2.05B 10-Q · filed 2017-05-08 | $2.11B derived: sum of 2 quarters · filed 2018-02-21 | $3.22B derived: sum of 3 quarters · filed 2018-02-21 | $3.62B derived: sum of 4 quarters · filed 2018-02-21 |
| 2017-01-01 | $60.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $1.17B derived: sum of 2 quarters · filed 2018-02-21 | $1.57B derived: sum of 3 quarters · filed 2018-02-21 | $1.57B 10-K · filed 2018-02-21 |
| 2016-10-02 | $1.11B derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $1.51B derived: sum of 2 quarters · filed 2016-11-04 | $1.51B 10-Q · filed 2016-11-04 | $1.94B derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-07-03 | $404.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $405.00M 10-Q · filed 2016-08-04 | $829.00M derived: sum of 3 quarters · filed 2017-02-27 | $829.00M derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-04-03 | $1.00M 10-Q · filed 2016-05-10 | $425.00M derived: sum of 2 quarters · filed 2017-02-27 | $425.00M derived: sum of 3 quarters · filed 2017-02-27 | $425.00M derived: sum of 4 quarters · filed 2017-02-27 |
| 2016-01-03 | $424.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $424.00M derived: sum of 2 quarters · filed 2017-02-27 | $424.00M derived: sum of 3 quarters · filed 2017-02-27 | $510.00M 10-K · filed 2017-02-27 |
| 2015-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $0.00 derived: sum of 2 quarters · filed 2015-10-30 | $86.00M 10-Q · filed 2015-10-30 | $672.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $86.00M 10-Q · filed 2015-07-31 | $672.00M derived: sum of 3 quarters · filed 2016-02-24 | $764.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2015-03-29 | $86.00M 10-Q · filed 2015-05-01 | $672.00M derived: sum of 2 quarters · filed 2016-02-24 | $764.00M derived: sum of 3 quarters · filed 2016-02-24 | $764.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-12-28 | $586.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $678.00M derived: sum of 2 quarters · filed 2016-02-24 | $678.00M derived: sum of 3 quarters · filed 2016-02-24 | $678.00M 10-K · filed 2016-02-24 |
| 2014-09-28 | $92.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $92.00M derived: sum of 2 quarters · filed 2014-10-30 | $92.00M 10-Q · filed 2014-10-30 | $92.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $0.00 10-Q · filed 2014-08-01 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $249.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2014-03-30 | $0.00 10-Q · filed 2014-05-02 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $249.00M derived: sum of 3 quarters · filed 2015-02-24 | $259.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $249.00M derived: sum of 2 quarters · filed 2015-02-24 | $259.00M derived: sum of 3 quarters · filed 2015-02-24 | $338.00M 10-K · filed 2015-02-24 |
| 2013-09-29 | $249.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $259.00M derived: sum of 2 quarters · filed 2013-11-04 | $338.00M 10-Q · filed 2013-11-04 | $940.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2013-06-30 | $10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $89.00M 10-Q · filed 2013-08-01 | $691.00M derived: sum of 3 quarters · filed 2014-02-21 | $745.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2013-03-31 | $79.00M 10-Q · filed 2013-05-03 | $681.00M derived: sum of 2 quarters · filed 2014-02-21 | $735.00M derived: sum of 3 quarters · filed 2014-02-21 | $6.18B derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-12-30 | $602.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $656.00M derived: sum of 2 quarters · filed 2014-02-21 | $6.10B derived: sum of 3 quarters · filed 2014-02-21 | $6.10B 10-K · filed 2014-02-21 |
| 2012-09-30 | $54.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.50B derived: sum of 2 quarters · filed 2012-11-09 | $5.50B 10-Q · filed 2012-11-09 | $5.70B derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-07-01 | $5.45B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $5.45B 10-Q · filed 2012-08-02 | $5.64B derived: sum of 3 quarters · filed 2013-02-22 | $5.89B derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-04-01 | $0.00 10-Q · filed 2012-05-07 | $198.00M derived: sum of 2 quarters · filed 2013-02-22 | $449.00M derived: sum of 3 quarters · filed 2013-02-22 | $513.00M derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-01-01 | $198.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $449.00M derived: sum of 2 quarters · filed 2013-02-22 | $513.00M derived: sum of 3 quarters · filed 2013-02-22 | $987.00M 10-K · filed 2013-02-22 |
| 2011-10-02 | $251.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $315.00M derived: sum of 2 quarters · filed 2011-11-08 | $789.00M 10-Q · filed 2011-11-08 | $786.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2011-07-03 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $538.00M 10-Q · filed 2011-08-09 | $535.00M derived: sum of 3 quarters · filed 2012-02-23 | $702.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2011-04-03 | $474.00M 10-Q · filed 2011-05-10 | $471.00M derived: sum of 2 quarters · filed 2012-02-23 | $638.00M derived: sum of 3 quarters · filed 2012-02-23 | |
| 2011-01-02 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $164.00M derived: sum of 2 quarters · filed 2012-02-23 | $397.00M 10-K · filed 2012-02-23 | |
| 2010-10-03 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | $400.00M 10-Q · filed 2010-11-10 | ||
| 2010-07-04 | $233.00M 10-Q · filed 2010-08-11 | |||
| 2010-01-03 | $672.00M 10-K · filed 2011-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |